Methocarbamol
Methocarbamol Tablets 500mg
Approved
Approval ID
cf931001-95bd-4900-98d5-f5ef54b49d99
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Feb 17, 2023
Manufacturers
FDA
Key Therapeutics
DUNS: 080318791
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
methocarbamol
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code70868-910
Application NumberANDA040489
Product Classification
M
Marketing Category
C73584
G
Generic Name
methocarbamol
Product Specifications
Route of AdministrationORAL
Effective DateFebruary 15, 2023
FDA Product Classification
INGREDIENTS (8)
MethocarbamolActive
Quantity: 500 mg in 1 1
Code: 125OD7737X
Classification: ACTIB
Silicon DioxideInactive
Code: ETJ7Z6XBU4
Classification: IACT
Magnesium StearateInactive
Code: 70097M6I30
Classification: IACT
Stearic AcidInactive
Code: 4ELV7Z65AP
Classification: IACT
Povidone K90Inactive
Code: RDH86HJV5Z
Classification: IACT
Starch, CornInactive
Code: O8232NY3SJ
Classification: IACT
Sodium Starch Glycolate Type A PotatoInactive
Code: 5856J3G2A2
Classification: IACT
WaterInactive
Code: 059QF0KO0R
Classification: IACT
Drug Labeling Information
SPL UNCLASSIFIED SECTION
LOINC: 42229-5Updated: 2/17/2023
Methocarbamol Tablets, USP 500 mg
Rx only